SCM
IMI

Stevens Capital Management’s Intermolecular, Inc. IMI Stock Holding History

Stevens Capital Management’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-20,558
Closed -$40K – 1341
2014
Q4 		$40K Sell
20,558
-2,404
-10% -$5.11K ﹤0.01% 961
2014
Q3 		$53K Buy
22,962
+300
+1% +$687 ﹤0.01% 958
2014
Q2 		$53K Buy
22,662
+8,291
+58% +$20.7K ﹤0.01% 1018
2014
Q1 		$40K Buy
+14,371
New +$52.3K ﹤0.01% 1036

Other funds holding IMI

RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
SPM
Symmetry Peak Management Radnor, Pennsylvania $369M AUM 148.4% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Stevens Capital Management's IMI Position: Q1 2015 in Review

Stevens Capital Management sold out of Intermolecular, Inc. (IMI) in Q1 2015, closing a stake of 20,558 shares — an estimated $40K sold.

Stevens Capital Management first reported a position in IMI in Q1 2014 and held it in 4 quarters. The position peaked at $53K in Q3 2014. 29 funds tracked by Wall St. Rank hold IMI as of Q1 2015.

  • Stevens Capital Management reported no remaining Intermolecular, Inc. position as of Q1 2015 after selling out during the quarter.
  • Stevens Capital Management sold 20,558 Intermolecular, Inc. shares in Q1 2015, an estimated $40K.
  • Stevens Capital Management first reported a position in Intermolecular, Inc. in Q1 2014 and held it in 4 quarters.
  • Stevens Capital Management's Intermolecular, Inc. position peaked at $53K in Q3 2014.
  • 29 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q1 2015.

Based on Stevens Capital Management's 13F filing for Q1 2015, filed 7 May 2015.